I-125 seeds with chemotherapy for progressive non-small-cell lung cancer after first-line treatment: a meta-analysis

BACKGROUND: Continuing therapy for aggressive non-small-cell lung cancer (NSCLC) after first-line treatment (FLT) is challenging. The clinical efficacy of second-line chemotherapy (SLCT) for progressive NSCLC is limited. In this meta-analysis, we aim to evaluate the clinical efficacy of the combinat...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zhong-Ke, Fan, Jing, Li, Fen-Qiang, Zhou, Shi-Yan, Xu, Yuan-Shun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004002/
https://www.ncbi.nlm.nih.gov/pubmed/35413934
http://dx.doi.org/10.1186/s13019-022-01820-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004002/
https://www.ncbi.nlm.nih.gov/pubmed/35413934
http://dx.doi.org/10.1186/s13019-022-01820-y

Ejemplares similares